Forensic investigation on behalf of a publicly-traded biotech firm

Forensic investigation on behalf of a publicly-traded biotech firm

Forensic Investigation

The Board of Directors of a publicly-traded biotech firm retained Stout to investigate whether transactions between the firm and related, privately-held parties were made on commercially reasonable terms. We reviewed many years of invoices, payments, restricted stock transactions, loans and services contracts. Our analysis evaluated whether the dollar value, stock value and other terms of numerous transactions were commercially reasonable. This is an ongoing investigation and Stout’s preliminary findings have been reported to the Board’s Special Litigation Committee.